Literature DB >> 11926740

Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6.

Haruhiko Taguchi, Motomichi Takahashi, Hiroyuki Yamaguchi, Takako Osaki, Akio Komatsu1, Yasunori Fujioka1, Shigeru Kamiya.   

Abstract

A mouse enterohaemorrhagic Escherichia coli (EHEC) infection model was developed with a combination of germ-free (GF) mice and hyper-toxigenic EHEC (HT-EHEC) O157:H7 strain 6. The HT-EHEC strain 6 produced both Shiga-like toxin (SLT)-1 1.0 microg/mI and SLT-2 8.2 microg/ml in vitro. Eight-week-old germ-free mice were inoculated intragastrically with 5.0 x 10(7) cfu of HT-EHEC strain 6. All GF mice challenged with the HT-EHEC developed ruffled fur and convulsion of limbs or hindleg weakness within 3 days after the challenge, culminating in death within 5 days. The HT-EHEC colonised well at a level of 10(8) - 10(9) cfu/g of faeces 5 days after the challenge. Both SLT-1 and SLT-2 were demonstrated in the faeces of the mice for 5 days after challenge. Histological examination of the colons of the infected mice showed congestion of the lamina propria mucosa, mild inflammatory cell infiltration and goblet cell depletion. In proximal tubules of the renal cortex, epithelial swelling with scattered necrotic cells was recognised. Endothelial swelling and mononuclear cell infiltration were also observed in the glomeruli. The brain showed acute neuronal necrosis in the cerebrum and slight loss of Purkinje cells in the cerebellum. Passive immunisation with anti-SLT antisera prolonged the life of the mice without anyneural symptoms. Microscopically, all tissue specimens from the passively immunised mice were not remarkable. These results indicate that the infection of GF mice with HT-EHEC is a useful animal model to study the pathogenicity of SLT-producing E. coliand the toxins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926740     DOI: 10.1099/0022-1317-51-4-336

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  19 in total

1.  Intestinal damage in enterohemorrhagic Escherichia coli infection.

Authors:  Zivile D Békássy; Carla Calderon Toledo; Gustav Leoj; Anncharlotte Kristoffersson; Shana R Leopold; Maria-Thereza Perez; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2010-09-01       Impact factor: 3.714

Review 2.  Bacterial Chat: Intestinal Metabolites and Signals in Host-Microbiota-Pathogen Interactions.

Authors:  Bruna C Lustri; Vanessa Sperandio; Cristiano G Moreira
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

3.  Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants.

Authors:  Haiqing Sheng; Hannah J Knecht; Indira T Kudva; Carolyn J Hovde
Journal:  Appl Environ Microbiol       Date:  2006-08       Impact factor: 4.792

Review 4.  Role of Shiga/Vero toxins in pathogenesis.

Authors:  Fumiko Obata; Tom Obrig
Journal:  Microbiol Spectr       Date:  2014-06

5.  Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7.

Authors:  K A Eaton; C Fontaine; D I Friedman; N Conti; C J Alteri
Journal:  Vet Pathol       Date:  2017-02-08       Impact factor: 2.221

6.  Contribution of gut bacteria to liver pathobiology.

Authors:  Gakuhei Son; Michael Kremer; Ian N Hines
Journal:  Gastroenterol Res Pract       Date:  2010-07-28       Impact factor: 2.260

7.  A novel murine infection model for Shiga toxin-producing Escherichia coli.

Authors:  Emily M Mallick; Megan E McBee; Vijay K Vanguri; Angela R Melton-Celsa; Katherine Schlieper; Brad J Karalius; Alison D O'Brien; Joan R Butterton; John M Leong; David B Schauer
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

8.  Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice.

Authors:  Kathryn A Eaton; David I Friedman; Gayle J Francis; Jessica S Tyler; Vincent B Young; Jennifer Haeger; Galeb Abu-Ali; Thomas S Whittam
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

9.  Restricted expression of shiga toxin binding sites on mucosal epithelium of mouse distal colon.

Authors:  Yasuyuki Imai; Takashi Fukui; Kohta Kurohane; Daisei Miyamoto; Yasuo Suzuki; Tomoyuki Ishikawa; Yousuke Ono; Masaki Miyake
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

10.  Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7.

Authors:  Takashi Asahara; Kensuke Shimizu; Koji Nomoto; Takashi Hamabata; Ayako Ozawa; Yoshifumi Takeda
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.